TALABAT:DFMTalabat Holding Plc Analysis
Data as of 2026-05-16 - not real-time
AED 0.88
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Talabat is trading at 0.883 AED, which sits above its 20‑day (0.876) and 50‑day (0.793) simple moving averages but remains below the 200‑day average (1.042), indicating a neutral technical stance. The RSI of 55.5 points to a market that is neither overbought nor oversold, while the MACD line (0.0236) under the signal line (0.0281) and a negative histogram signal a bearish momentum bias. Volume is on a downtrend and 30‑day volatility is elevated at 33.7 %, though the stock’s beta of 0.63 suggests lower systematic risk. On the fundamentals side, revenue is expanding at a robust 25.7 % YoY with a profit margin of 11.8 %, yet the price‑to‑book of 8.0 and a DCF fair value of 0.76 AED imply the market is pricing in a modest premium. The dividend yield is eye‑catching at 9.48 %, but a payout ratio of zero and zero free‑cash‑flow raise questions about its sustainability. Analyst consensus is bullish (average target ≈ 1.28 AED, upside ~46 %), while the fear‑and‑greed index at Extreme Greed reflects strong market optimism. Finally, the historical max drawdown of -57 % underscores the potential for sharp downside moves despite the current sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal with negative histogram
- Decreasing volume and high short‑term volatility
- Price hovering near immediate support at 0.782 AED
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth of 25.7 % YoY
- Analyst consensus bullish with median target >1.27 AED
- Attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Current price above DCF fair value indicating slight overvaluation
- Uncertainty around dividend sustainability and zero free cash flow
- Competitive consumer‑cyclical internet retail sector with medium risk
Key Metrics & Analysis
Financial Health
Revenue Growth25.70%
Profit Margin11.81%
P/E Ratio14.7
Debt/Equity21.61
P/B Ratio8.0
Op. Cash FlowAED673.5M
Technical Analysis
TrendNeutral
RSI55.5
SupportAED 0.78
ResistanceAED 0.94
MA 20AED 0.88
MA 50AED 0.79
MA 200AED 1.04
MACDBearish
VolumeDecreasing
Fear & Greed Index88.52
Valuation
Fair ValueAED 0.76
Target PriceAED 1.29
Upside/Downside46.00%
GradeFair
TypeBlend
Dividend Yield9.48%
Risk Assessment
Beta0.63
Volatility33.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.